1. Home
  2. Stocks
  3. Eris Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Eris Lifesciences

    Mid Cap
    ₹1,011.95
    -18.2 (-1.77%)
    06 July, 2024 16:14 BSE: 540596 NSE: ERIS ISIN: INE406M01024

    Start SIP in Eris Lifesciences

    Start SIP

    Eris Lifesciences Performance

    Day Range

    • Low 1,007
    • High 1,047
    ₹ 1,011

    52 Week Range

    • Low 693
    • High 1,090
    ₹ 1,011
    • Open Price1,034
    • Previous Close1,030
    • Volume110955

    Eris Lifesciences Share Price

    • Over 1 Month + 10.31%
    • Over 3 Month + 18.86%
    • Over 6 Month + 8.46%
    • Over 1 Year + 45.01%

    Eris Lifesciences Key Statistics

    P/E Ratio 35.1
    PEG Ratio 12.5
    Market Cap Cr
    Price to Book Ratio 4.3
    EPS 22
    Dividend 0
    Relative Strength Index 53.22
    Money Flow Index 74.43
    MACD Signal 30.96
    Average True Range 36.58
    Eris Lifesciences Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 332316410411308
    Operating Expenses Qtr Cr 262250265256203
    Operating Profit Qtr Cr 7974144156111
    Depreciation Qtr Cr 2928252017
    Interest Qtr Cr 2915773
    Tax Qtr Cr 232228
    Net Profit Qtr Cr 403211811188
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,5221,348
    Operating Expenses Annual Cr 1,033826
    Operating Profit Annual in Cr 454505
    Depreciation Cr 10265
    Interest Annual Cr 5721
    Tax Annual Cr 2939
    Net Profit Annual Cr 300398
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 336322
    Cash from Investing Activity Annual Cr -2,492-513
    Cash from Financing Annual Activity Cr 2,160194
    Net Cash Flow Annual Cr 3
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,5242,222
    Fixed Assets Annual Cr 1,516898
    Total Non Current Assets Annual Cr 3,4732,232
    Total Current Assets Annual Cr 1,877552
    Total Assets Annual Cr 5,3502,784
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 186163
    ROE Annual % 1218
    ROCE Annual % 1318
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3339
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 547483505467397
    Operating Expenses Qtr Cr 402311324297284
    Operating Profit Qtr Cr 148176181170119
    Depreciation Qtr Cr 5446424135
    Interest Qtr Cr 331816179
    Tax Qtr Cr -31441914
    Net Profit Qtr Cr 711031239565
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,0331,696
    Operating Expenses Annual Cr 1,3341,148
    Operating Profit Annual in Cr 675537
    Depreciation Cr 183117
    Interest Annual Cr 8526
    Tax Annual Cr 3430
    Net Profit Annual Cr 392382
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 486292
    Cash from Investing Activity Annual Cr -1,828-982
    Cash from Financing Annual Activity Cr 1,380688
    Net Cash Flow Annual Cr -2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,5862,196
    Fixed Assets Annual Cr 3,4862,258
    Total Non Current Assets Annual Cr 4,7472,903
    Total Current Assets Annual Cr 2,302765
    Total Assets Annual Cr 7,0493,667
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 237163
    ROE Annual % 1517
    ROCE Annual % 1113
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3533
    Invest in Eris Lifesciences

    Eris Lifesciences Technicals

    EMA & SMA

    Current Price
    ₹1,011.95
    -18.2 (-1.77%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹1,013.66
    • 50 Day
    • ₹965.95
    • 100 Day
    • ₹929.06
    • 200 Day
    • ₹885.56
    • 20 Day
    • ₹1,027.79
    • 50 Day
    • ₹946.02
    • 100 Day
    • ₹906.11
    • 200 Day
    • ₹897.59

    Eris Lifesciences Resistance and Support

    PIVOT
    ₹1,022.14
    Resistance
    First Resistance 1,037.17
    Second Resistance 1,062.38
    Third Resistance 1,077.42
    RSI 53.22
    MFI 74.43
    MACD Single Line 30.96
    MACD 24.85
    Support
    First Support 996.92
    Second Support 981.88
    Third Supoort 956.67

    Eris Lifesciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 117,489 6,468,944 55.06
    Week 132,354 6,633,572 50.12
    1 Month 208,653 10,167,647 48.73
    6 Month 222,377 13,169,166 59.22

    Eris Lifesciences Result Highlights

    Eris Lifesciences Synopsis

    NSE-Medical-Biomed/Biotech

    Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1330.73 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2023. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.
    Market Cap 13,770
    Sales 1,487
    Shares in Float 6.12
    No of funds 142
    Yield
    Book Value 5.46
    U/D Vol ratio 1.1
    LTDebt / Equity 19
    Alpha 0.06
    Beta 0.71

    Eris Lifesciences Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 54.9%54.9%54.91%52.86%
    Mutual Funds 14.92%13.85%13.86%10.27%
    Insurance Companies 0.01%
    Foreign Portfolio Investors 14.27%13.13%13.2%13.78%
    Financial Institutions/ Banks
    Individual Investors 14.24%15.67%15.47%22.07%
    Others 1.67%2.45%2.56%1.01%

    Eris Lifesciences Management

    Name Designation
    Mr. Amit Bakshi Chairperson & Managing Director
    Mr. Krishnakumar Vaidyanathan COO & Executive Director
    Mr. Inderjeet Singh Negi Executive Director
    Mr. Kaushal Shah Executive Director
    Mr. Rajeev Dalal Independent Director
    Mr. Vasudevan Sujesh Independent Director
    Ms. Kalpana Unadkat Independent Director
    Mr. Prashant Gupta Independent Director

    Eris Lifesciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Eris Lifesciences Corporate Action

    Date Purpose Remarks
    2024-05-21 Audited Results & Fund Raising
    2024-02-13 Quarterly Results
    2023-11-08 Quarterly Results
    2023-08-07 Quarterly Results
    2023-05-17 Audited Results
    Date Purpose Remarks
    2022-08-16 INTERIM Rs.7.35 per share(735%)Interim Dividend
    2021-08-06 INTERIM Rs.6.01 per share(601%)Interim Dividend

    Eris Lifesciences MF Shareholding

    Name Amount(cr)
    HDFC Small Cap Fund Growth 29,175
    UTI Flexi Cap Fund Regular Plan Growth 23,972
    HDFC Hybrid Equity Fund Growth 23,138
    HDFC Large and Mid Cap Fund Growth 19,454
    HDFC Multi Cap Fund Regular Growth 13,815

    Eris Lifesciences FAQs

    What is Share Price of Eris Lifesciences ?

    Eris Lifesciences share price is ₹1,011 As on 06 July, 2024 | 16:00

    What is the Market Cap of Eris Lifesciences ?

    The Market Cap of Eris Lifesciences is ₹13770.1 Cr As on 06 July, 2024 | 16:00

    What is the P/E ratio of Eris Lifesciences ?

    The P/E ratio of Eris Lifesciences is 35.1 As on 06 July, 2024 | 16:00

    What is the PB ratio of Eris Lifesciences ?

    The PB ratio of Eris Lifesciences is 4.3 As on 06 July, 2024 | 16:00

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.